相关实验视频

Updated: Jan 12, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

解读KIF18A在骨肉瘤进展中的作用:综合性分析和实验验证

Zhiqian Gu^1,2,3, Songou Zhang¹, Xudong Hu^2,3

¹Health Science Center, Ningbo University, 315211 Ningbo, Zhejiang, China.

Frontiers in bioscience (Landmark edition)

|November 6, 2025

概括

在骨髓瘤 (OS) 中,KIF18A被上调,促进癌症的进展和转移. 准KIF18A可能为这种侵袭性骨癌提供了一个新的治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

骨髓瘤 (OS) 是一种高度侵略性的骨癌,以转移而闻名.
识别分子驱动因素对于有效的OS疗法至关重要.
在OS进展和转移中KIF18A的作用基本上是未知的.

研究的目的:

研究KIF18A在骨髓瘤 (OS) 发展和进展中的作用.
探索KIF18A作为潜在的预后生物标志物和OS中的治疗标.

主要方法:

对OS数据集的差异基因表达分析 (GSE126209,TARGET).
功能性测试 (体外和体内) 来评估KIF18A对OS细胞行为和瘤生长的影响.
路径丰富分析 (GSEA),瘤免疫微环境分析 (CIBERSORT) 和药物敏感性分析.

主要成果:

KIF18A在OS组织中显著升级,并与转移和不良结果相关.
在体外,KIF18A促进OS细胞的增殖,入侵,迁移,并抑制细胞灭绝.
在体内,KIF18A Knockdown抑制瘤生长,并与免疫抑制性瘤微环境相关.

结论:

在OS中,KIF18A作为一个关键的瘤基因,驱动进展和转移.
KIF18A是一种有前途的预后生物标志物和骨髓瘤的治疗标.
KIF18A失调与瘤性途径,免疫抑制和潜在的免疫疗法耐药性有关.

关键词:

这就是OS OS OS OS.灭症 (apoptosis) 是一种死亡的过程.生物的生物的生物的生物.免疫系统是免疫系统的.

更多相关视频

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...